14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $4.00 Wednesday, 1st May 2024 CYCC stock ended at $2.65. This is 25.00% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 111.64% from a day low at $1.89 to a day high of $4.00.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Nov 03, 2021 $5.18 $5.18 $5.01 $5.03 30 447
Nov 02, 2021 $5.10 $5.24 $5.01 $5.14 52 814
Nov 01, 2021 $4.95 $5.08 $4.91 $5.02 38 575
Oct 29, 2021 $4.95 $4.95 $4.80 $4.91 50 638
Oct 28, 2021 $4.86 $4.99 $4.86 $4.91 12 267
Oct 27, 2021 $4.97 $4.97 $4.85 $4.86 59 948
Oct 26, 2021 $4.87 $5.03 $4.85 $4.97 39 248
Oct 25, 2021 $5.03 $5.09 $4.80 $4.90 57 943
Oct 22, 2021 $5.19 $5.26 $5.01 $5.03 38 036
Oct 21, 2021 $5.25 $5.25 $5.01 $5.24 90 705
Oct 20, 2021 $5.30 $5.47 $5.14 $5.20 59 337
Oct 19, 2021 $5.42 $5.42 $5.28 $5.32 38 165
Oct 18, 2021 $5.53 $5.54 $5.26 $5.36 64 185
Oct 15, 2021 $5.58 $5.76 $5.54 $5.57 40 731
Oct 14, 2021 $5.65 $5.77 $5.60 $5.71 55 640
Oct 13, 2021 $5.41 $5.85 $5.39 $5.72 195 947
Oct 12, 2021 $5.35 $5.54 $5.31 $5.44 42 394
Oct 11, 2021 $5.29 $5.46 $5.29 $5.42 111 230
Oct 08, 2021 $5.34 $5.54 $5.24 $5.30 41 042
Oct 07, 2021 $5.41 $5.49 $5.20 $5.34 100 546
Oct 06, 2021 $5.26 $5.53 $5.24 $5.41 97 456
Oct 05, 2021 $5.29 $5.42 $5.25 $5.28 75 179
Oct 04, 2021 $5.43 $5.43 $5.15 $5.32 93 181
Oct 01, 2021 $5.43 $5.48 $5.05 $5.43 284 259
Sep 30, 2021 $5.65 $5.75 $5.26 $5.27 231 516
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT